Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy-Reference-Cited by-同舟云学术

Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy

Published:2019-10-16 Issue:2 Volume:92 Page:210-218
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Saito Yuhei¹²,Imamura Michio¹²,Uchida Takuro¹²,Osawa Mitsutaka¹²^ORCID,Teraoka Yuji¹²,Fujino Hatsue¹²,Nakahara Takashi¹²,Ono Atsushi¹²,Murakami Eisuke¹²,Kawaoka Tomokazu¹²,Miki Daiki¹²,Tsuge Masataka²³,Serikawa Masahiro¹²,Aikata Hiroshi¹²,Abe‐Chayama Hiromi²⁴,Hayes C. Nelson¹²,Chayama Kazuaki¹²^ORCID

Affiliation:

1. Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health ScienceHiroshima University Hiroshima Japan

2. Research Center for Hepatology and GastroenterologyHiroshima University Hiroshima Japan

3. Natural Science Center for Basic Research and DevelopmentHiroshima University Hiroshima Japan

4. Center for Medical Specialist Graduate Education and Research, Institute of Biomedical and Health SciencesHiroshima University Hiroshima Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25602

Reference37 articles.

1. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

2. Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C

3. Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan

4. Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients

5. Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and Consequences of Genetic Variation in Hepatitis C Virus (HCV);Current Topics in Microbiology and Immunology;2023

2. Safety and efficacy of sofosbuvir-velpatasvir: A meta-analysis;Medicine;2022-10-21

3. Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir;Biochemistry and Biophysics Reports;2022-07

4. Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing;Scientific Reports;2022-04-30

5. Mutations Identified in the Hepatitis C Virus (HCV) Polymerase of Patients with Chronic HCV Treated with Ribavirin Cause Resistance and Affect Viral Replication Fidelity;Antimicrobial Agents and Chemotherapy;2020-11-17